The impact of new tuberculosis diagnostics on transmission: why context matters
Authors:
- Hsien-Ho LinHLHsien-Ho Lin
- David DowdyDDDavid Dowdy
- Christopher DyeCDChristopher Dye
- Ted CohenTCTed Cohen
- 1 October 2012
- journal article
- research article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 90 (10) , 739-747
Abstract
To estimate the impact of new tuberculosis diagnostics on tuberculosis transmission given the complex contextual factors that can lead to patient loss before diagnosis or treatment. An epidemic model of tuberculosis specifying discrete steps along the tuberculosis diagnostic pathway was constructed. The model was calibrated to the epidemiology of tuberculosis and human immunodeficiency virus (HIV) infection in the United Republic of Tanzania and was used to assess the impact of a new diagnostic tool with 70% sensitivity for smear-negative pulmonary tuberculosis. The influence of contextual factors on the projected epidemic impact of the new diagnostic tool over the decade following introduction was explored. With the use of smear microscopy, the incidence of tuberculosis will decline by an average of 3.94% per year. If the new tool is added, incidence will decline by an annual 4.25%. This represents an absolute change of 0.31 percentage points (95% confidence interval: 0.04-0.42). However, the annual decline in transmission with use of the new tool is less when existing strategies for the diagnosis of smear-negative cases have high sensitivity and when symptomatic individuals delay in seeking care. Other influential contextual factors include access to tuberculosis care, patient loss before diagnosis, initial patient default after diagnosis and treatment success rate. When implementing and scaling up the use of a new diagnostic tool, the operational context in which diagnosis and treatment take place needs to be considered.Keywords
This publication has 30 references indexed in Scilit:
- A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools [State of the art series. Operational research. Number 8 in the series]The International Journal of Tuberculosis and Lung Disease, 2011
- LED Fluorescence Microscopy for the Diagnosis of Pulmonary Tuberculosis: A Multi-Country Cross-Sectional EvaluationPLOS Medicine, 2011
- Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools.2010
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- New and improved tuberculosis diagnostics: evidence, policy, practice, and impactCurrent Opinion in Pulmonary Medicine, 2010
- Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populationsProceedings of the National Academy of Sciences, 2006
- 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them?2005
- Prospects for worldwide tuberculosis control under the WHO DOTS strategyThe Lancet, 1998
- Modeling the impact of global tuberculosis control strategiesProceedings of the National Academy of Sciences, 1998
- Uncertainty and Sensitivity Analysis of the Basic Reproductive Rate: Tuberculosis as an ExampleAmerican Journal of Epidemiology, 1997